DOCS 250117 12.50P (DOCS250117P12500) Stock Options, News & Quotes

US OptionsDetailed Quotes

DOCS250117P12500

Watchlist

0.05
0.000.00%

15min DelayTrading Jan 17 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC
Yahoo FinanceJan 23 03:43 ET
4 MedTech Stocks Poised to Thrive Under Second Trump Presidency
Zacks Jan 22 11:00 ET
What Software Stocks Like Microsoft Need to Reclaim Record Highs -- Barrons.com
Barron'sJan 22 02:30 ET
Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025
BusinesswireJan 16 16:01 ET
Demystifying Doximity: Insights From 15 Analyst Reviews
BenzingaJan 13 15:00 ET
Doximity Is Maintained at Equal-Weight by Wells Fargo
Dow JonesJan 13 10:24 ET · Ratings

Comments

Ben the Oracle

Nov 8, 2024 18:26

SHORT SQUEEZED!!

$Doximity (DOCS.US)$ guys be very cafeful jumping on top of this move. This is just a pressure cooker from short squeeze. This will go back down Next week. I would not touch DOCS if I where you. Be patient and wait for better entry.

Stock_Drift

Nov 8, 2024 04:21

Pre Market Ticks. 5:20am 11/8

$Volato Group (SOAR.US)$ $Toast (TOST.US)$ $Upstart (UPST.US)$ $Icecure Medical (ICCM.US)$ $Five9 (FIVN.US)$ $Lumentum (LITE.US)$ $Nature's Miracle (NMHI.US)$ $Innodata (INOD.US)$ $Northann (NCL.US)$ $LI-CYCLE (LICY.US)$ $Doximity (DOCS.US)$ $Tivic Health Systems (TIVC.US)$ $DevvStream (DEVS.US)$
📊⚡️📊

Stock_Drift

Nov 7, 2024 17:28

👍
$Doximity (DOCS.US)$

Jerry Kronenberg: Doximity Gains Nearly 40% After Hours on Earnings and Revenue Beats and Well-Received Guidance

Stock_Drift

Nov 7, 2024 16:39

After Hours Ticks. 5:37pm

$The Glimpse (VRAR.US)$ $Inspirato (ISPO.US)$ $Toast (TOST.US)$ $Altisource Portfolio (ASPS.US)$ $Visionary Holdings (GV.US)$ $Jeffs' Brands (JFBR.US)$ $WEBTOON Entertainment (WBTN.US)$ $Lumentum (LITE.US)$ $Volato Group (SOAR.US)$ $Five9 (FIVN.US)$ $Innodata (INOD.US)$ $Tivic Health Systems (TIVC.US)$ $Doximity (DOCS.US)$ $LI-CYCLE (LICY.US)$ $Northann (NCL.US)$
📊⚡️📊

Jerry Kronenberg

Nov 7, 2024 15:53

Columns Doximity Gains Nearly 40% After Hours on Earnings and Revenue Beats and Well-Received Guidance

$Doximity (DOCS.US)$ soared nearly 40% after hours on Thursday after the medical-records platform beat analyst estimates for quarterly earnings and revenues and guided the current quarter to better-than-expected sales.
DOCS gained 38% to $59.90 shortly before 5 p.m. ET after reporting $0.30 in non-GAAP earnings per share, exceeding the $0.26 that analysts had expected, according to published reports. Rev...